Molecular imaging developer Gamma Medica announced that Einstein Medical Center Philadelphia has committed to purchasing its LumaGem molecular breast imaging (MBI) system.
The system will be installed at the Marion-Louise Saltzman Women's Center at the medical center and will be the first clinical LumaGem MBI system in Pennsylvania.
Molecular breast imaging is a secondary screening and diagnostic tool useful for women who have dense breast tissue and women with a high risk of breast cancer.
![A 53-year-old patient (patient number four) with a recurrent pituitary adenoma with extension of a cystic component of disease to the medial temporal lobe apparent on MRI (contoured in blue), and extension of disease to the left sphenoid bone and orbital apex apparent on [68Ga]Ga-DOTA-TATE (contoured in yellow).](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/04/pituitary-tumor.QGsEnyB4bU.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
